1700016K19Rik activators encompass a variety of chemical compounds that facilitate its function through several signaling mechanisms. Forskolin, IBMX, Isoproterenol, Epinephrine, Dibutyryl-cAMP (db-cAMP), and N6-Benzoyladenosine 3',5'-cyclic monophosphate (6-Bnz-cAMP) all work by elevating intracellular cAMP levels, with Forskolin directly stimulating adenylyl cyclase and IBMX inhibiting phosphodiesterases, while Isoproterenol and Epinephrine exert their effects through adrenergic receptors, and db-cAMP and 6-Bnz-cAMP serve as cAMP analogs. The increased cAMP subsequently activates PKA and other cAMP-dependent pathways, which can enhance the activity of 1700016K19Rik through phosphorylation events and interaction with downstream targets. Similarly, the activation of PKC by Phorbol 12-myristate 13-acetate (PMA) could modify the activity of proteins that are in the regulatory network of 1700016K19Rik, leading to an upregulation of its functional state.
The modulation of intracellular calcium levels is another avenue through which the activity of 1700016K19Rik can be boosted, as seen with the calcium ionophores A23187 and Ionomycin, which by raising intracellular calcium, activate calcium-dependent signaling pathways, potentially enhancing 1700016K19Rik activity. The cAMP pathway and calcium signaling are intertwined with the cellular processes that 1700016K19Rik is part of, and their modulation by these compounds can lead to a more active form of the protein. Anisomycin, which activates the JNK pathway, and Okadaic Acid, which inhibits protein phosphatases, are both capable of altering the phosphorylation status of proteins associated with 1700016K19Rik, suggesting a more indirect route of enhancing its activity. Nitrendipine's blockade of L-type calcium channels may also contribute to the activation of 1700016K19Rik by modifying downstream calcium-dependent signaling. Collectively, these activators work through distinct biochemical pathways to enhance the activity of 1700016K19Rik, ensuring that the protein's function is amplified in the context of the cell's signaling architecture.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases which increases intracellular cAMP levels, thereby potentially enhancing 1700016K19Rik activity through cAMP-dependent signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in numerous signaling pathways that could lead to enhanced activity of 1700016K19Rik by modulating related signaling proteins. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as an ionophore that increases intracellular calcium levels, which could enhance the activity of 1700016K19Rik by activating calcium-dependent signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially enhancing 1700016K19Rik activity through calcium-mediated signaling mechanisms. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that can permeate cell membranes and directly activate cAMP-dependent pathways, potentially enhancing the activity of 1700016K19Rik. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors to increase cAMP production, which could lead to enhanced 1700016K19Rik activity through cAMP-mediated signaling. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
6-Bnz-cAMP is a cAMP analog that selectively activates PKA, potentially enhancing the activity of 1700016K19Rik through PKA-dependent signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that could enhance the activity of 1700016K19Rik by influencing JNK signaling pathways that intersect with 1700016K19Rik regulatory mechanisms. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, potentially enhancing the activity of 1700016K19Rik by preventing dephosphorylation of proteins within its signaling pathways. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $109.00 $160.00 $458.00 | 6 | |
Nitrendipine blocks L-type calcium channels, leading to altered calcium signaling, which could indirectly enhance the activity of 1700016K19Rik by affecting calcium-dependent processes. | ||||||